文献速递中药与中成药合理使用中医内科

半夏天麻汤与黄连解毒汤对依度沙班药代动力学的影响

Impact of Banhabaekchulcheonmatang (Banxia Baizhu Tianma Tang) and Hwangryeonhaedoktang (Huang Lian Jie Du Tang) on edoxaban: Herb-drug interaction study in healthy subjects.
PubMed 文献 · J Ethnopharmacol · 2024-10-24

该研究在韩国健康志愿者中开展随机、开放、三周期、三治疗、两序列临床试验,评估半夏天麻汤(BBCT)与黄连解毒汤(HRHDT)对依度沙班及其活性代谢物M4的影响。结果显示两方剂不影响依度沙班AUC,但使其Cmax降低18.5%-28.1%,M4的Cmax降低16.8%-27.1%,而基于aPTT和PT的药效学参数等效。

要点

  • BBCT与HRHDT不改变依度沙班AUC,但使其Cmax降低18.5%-28.1%。
  • 两方剂使M4的Cmax降低16.8%-27.1%,AUC略降。
  • 基于aPTT和PT的药效学参数在合用与单用间等效。

核心结论

  • BBCT和HRHDT对依度沙班及M4的药代动力学影响较小,药效学参数等效。

研究设计与样本

  • 韩国健康志愿者参与的随机、开放、三周期、三治疗、两序列临床试验。
  • 依度沙班单用60 mg或与BBCT/HRHDT(每日三次,共六天)合用。

主要发现

  • 依度沙班AUC不受BBCT或HRHDT影响。
  • 依度沙班Cmax降低18.5%-28.1%。
  • M4的AUC略降,Cmax降低16.8%-27.1%。
  • 基于aPTT和PT的药效学参数等效。

临床怎么用

  • 合用BBCT或HRHDT时,依度沙班抗凝效应指标(aPTT、PT)未见等效性改变,但Cmax下降需关注。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

ETHNOPHARMACOLOGICAL RELEVANCE: Concurrent use of traditional herbal medicines and conventional drugs, particularly for stroke treatment, is widespread, raising concerns about potential drug interactions. AIM OF THE STUDY: This clinical study aimed to investigate interactions between edoxaban, a direct oral anticoagulant, and two traditional herbal medicines commonly used for stroke: Banhabaekchulcheonmatang (BBCT) and Hwangryeonhaedoktang (HRHDT). MATERIALS AND METHODS: Korean healthy volunteers participated in a randomized, open-label, three-period, three-treatment, two-sequence clinical study. Treatments consisted of a single oral dose of edoxaban tablet (60 mg) in the presence or absence of multiple doses of BBCT or HRHDT three times daily for six days. Pharmacokinetic and pharmacodynamic parameters of edoxaban and its active metabolite M4 were assessed following administration of edoxaban alone or in co-administration with BBCT or HRHDT. RESULTS: When edoxaban was co-administered with BBCT or HRHDT, the area under the curve (AUC) of edoxaban remained unaffected. However, its peak concentrations (Cmax) were decreased by 18.5%-28.1%. Similarly, co-administration of edoxaban with BBCT or HRHDT slightly decreased the AUC of M4 and reduced its Cmax by 16.8%-27.1%. Results revealed that BBCT and HRHDT had a minor impact on pharmacokinetics of edoxaban and M4. Despite alterations in systemic exposures, all pharmacodynamic parameters of edoxaban derived from activated partial thromboplastin time and prothrombin time were equivalent irrespective of herbal medicine co-administration. CONCLUSIONS: These findings contribute to our understanding of potential interactions between conventional anticoagulants and traditional herbal medicines, highlighting the need for comprehensive evaluation in clinical practice.

来源:J Ethnopharmacol,查看原文。版权归原作者所有。

引用

  1. Cho SJ, Song J, Kang DW, et al. Impact of Banhabaekchulcheonmatang (Banxia Baizhu Tianma Tang) and Hwangryeonhaedoktang (Huang Lian Jie Du Tang) on edoxaban: Herb-drug interaction study in healthy subjects. J Ethnopharmacol. 2024. PMID: 39461388. doi:10.1016/j.jep.2024.118997

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。